Astrana Health (NASDAQ:ASTH) Shares Down 2.7% - Here's What Happened

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) were down 2.7% on Tuesday . The stock traded as low as $32.58 and last traded at $32.58. Approximately 44,044 shares were traded during trading, a decline of 80% from the average daily volume of 217,443 shares. The stock had previously closed at $33.47.

Analyst Ratings Changes

ASTH has been the subject of several research reports. KeyCorp began coverage on Astrana Health in a research note on Friday, October 11th. They set a "sector weight" rating for the company. Robert W. Baird upped their price target on shares of Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a research report on Wednesday, November 13th. TD Cowen assumed coverage on Astrana Health in a research note on Monday, October 14th. They set a "buy" rating and a $66.00 target price on the stock. Macquarie raised shares of Astrana Health to a "hold" rating in a research report on Monday, December 16th. Finally, BTIG Research lifted their target price on shares of Astrana Health from $60.00 to $70.00 and gave the company a "buy" rating in a research note on Thursday, October 3rd. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $65.17.

Astrana Health Trading Up 0.0 %

The company has a 50-day simple moving average of $46.70 and a 200-day simple moving average of $47.86. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The stock has a market cap of $1.88 billion, a P/E ratio of 25.75, a P/E/G ratio of 1.80 and a beta of 1.14.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting analysts' consensus estimates of $0.33. The business had revenue of $478.71 million during the quarter, compared to analyst estimates of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same quarter last year, the business posted $0.47 earnings per share. On average, sell-side analysts forecast that Astrana Health, Inc. will post 1.16 EPS for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. State Street Corp bought a new stake in Astrana Health in the third quarter valued at approximately $91,966,000. Geode Capital Management LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at $58,995,000. FMR LLC bought a new stake in shares of Astrana Health in the 3rd quarter valued at $48,413,000. SteelPeak Wealth LLC acquired a new stake in Astrana Health during the 3rd quarter worth $39,398,000. Finally, Loomis Sayles & Co. L P acquired a new stake in Astrana Health during the 3rd quarter worth $30,251,000. Institutional investors own 52.77% of the company's stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.